Academic internal medicine physician and clinical AI physician-builder
Clinical Assistant Professor, Elson S. Floyd College of Medicine, Washington State University
Richland, Washington rejeeshmenon85@gmail.com rejeesh.menon@wsu.eduAcademic internal medicine physician and clinical assistant professor who also builds the software his clinics run on. Ten years of inpatient medicine in U.S. community hospitals; a translational research background that took an amino-acid formulation from the Ussing chamber to a Nestle-licensed product; a seven-clinic dermatology group in India that serves as a live environment for shipping and testing clinical software. Builds solo with Claude Code CLI, writing the prompts and owning the clinical logic, the human-in-the-loop boundaries, the safety rules for what generative output may say to a patient, and the compliance decisions.
Each system was specified, built and shipped solo, with AI-assisted development (Claude Code CLI and agentic tooling) and no other engineers. Rejeesh writes the prompts and owns the clinical logic, the autonomy boundaries and the compliance decisions.
Designed and built SuperHuman Built and shipped DermaVue Clinic OS Built and shipped DermaVue Commerce Built and maintains dermavue.com
Consolidates labs, wearable data and prescription history into physician-reviewed guidance.
Author of the clinical logic and the autonomy boundary, meaning what the tool decides on its own and what requires physician sign-off.
Every piece of generated guidance is checked against source data during the pilot.
Compliance decisions: BAA-covered data boundary, synthetic-data development, and a decision-support design built to meet the FDA's non-device clinical decision support criteria, not an autonomous diagnostic device.
Piloting inside the DermaVue clinic network.
Patient messaging for all seven clinics across WhatsApp, Instagram and Facebook Messenger, with automatic lead qualification into one CRM.
Inbound lead integration via webhooks with clinic routing and de-duplication.
Designed the automated responder "Priya", including forbidden clinical topics and red-flag escalation rules, with live log review each release.
Search-optimized storefront with an ingredient database linking each product to the evidence behind its formulation.
Condition, procedure and location pages with hand-coded medical schema and answer-engine-oriented structure.
The safety-design decisions below are self-reported. Unlike the licenses and publications elsewhere on this page, no external body yet certifies clinical-AI autonomy-boundary design of this kind.
Postdoctoral research scholar at the University of Florida (2011 to 2013). The team's intestinal-transport work produced enterade, an amino-acid rehydration formulation funded by NASA/NSBRI, licensed worldwide to Nestle Health Science (2018), and studied at Harvard, Dana-Farber, the U.S. Army and the University of Kentucky. Co-investigator on the first randomized trial in chikungunya arthritis (120 patients, GCP conditions), now cited in UpToDate and national guidelines.
Bench research Ussing-chamber intestinal-transport work, University of Florida, 2011 to 2013 Formulation enterade, an amino-acid rehydration formulation External validation NASA/NSBRI funding; studied at Harvard, Dana-Farber, the U.S. Army and the University of Kentucky Commercial license Licensed worldwide to Nestle Health Science, 2018
223 citations, h-index 6, i10-index 6, 96 citations since 2021. Google Scholar, September 2026.
These 3 publications account for 119 of the 223 total citations above; the remainder comes from publications not individually listed on this page.
From bench to deployed, governed system:
Ussing-chamber intestinal-transport work, University of Florida, 2011 to 2013
DermaVue Skin & Hair Clinics, 7 clinics
Compliance decisions: BAA-covered data boundary, synthetic-data development, and a decision-support design built to meet the FDA's non-device clinical decision support criteria, not an autonomous diagnostic device.